Determination of plasma [18F]-6-fluorodopa during positron emission tomography: Elimination and metabolism in carbidopa treated subjects
- 8 December 1986
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 39 (23), 2243-2252
- https://doi.org/10.1016/0024-3205(86)90403-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Determination of m- and p-O-methylated products of l-3,4-dihydroxyphenylalanine using high-performance liquid chromatography and electrochemical detectionAnalytical Biochemistry, 1985
- The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: The mechanism of action in the treatment of parkinsonismAnnals of Neurology, 1985
- Positron emission tomography after MPTP: observations relating to the cause of Parkinson's diseaseNature, 1985
- The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: Significance in the development of 18F-pett scanning agentsBiochemical and Biophysical Research Communications, 1985
- Major gene model for the inheritance of catechol-o-methyltransferase activity in five large familiesAmerican Journal of Medical Genetics, 1984
- The Cerebral Metabolism of L-DihydroxyphenylalaninePharmacology, 1984
- Dopamine visualized in the basal ganglia of living manNature, 1983
- Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolitesJournal of Pharmacological Methods, 1982
- Direct extraction radioassay for cathechol-o-methyl-transferase activityBiochemical Pharmacology, 1978
- 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1972